Incyte Corporation (0J9P.L) Stock Price
$85.58 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
7 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Incyte Corporation, AI stock picks, stock alerts and much more.
0J9P.L AI Stock Analysis
AI stock analysis for 0J9P.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Incyte Corporation (0J9P.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Incyte Corporation (0J9P.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Incyte Corporation (0J9P.L), currently trading at $85.58, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0J9P.L
-
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally.
-
Symbol
0J9P.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
16.7B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$398.5 0.5% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$136.1 1.2% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$9.46 2.9% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$7.25 1.7% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$12.17 0.5% |
5 |
News
0J9P.L Alternative Data
Web Traffic
Incyte Corporation receives an estimated 69841 monthly visitors to incyte.com.
-
Web Traffic
69841
-
Change from Previous Month
22.1%
-
3 Month Change
34%
-
YoY Change
34%
Facebook Engagement
Incyte Corporation has engaged 145 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
145
-
Daily Change
2.1%
-
1 Month Change
34.4%
-
3 Month Change
90.7%
-
YoY Change
90.7%
Instagram Followers
Incyte Corporation has 1,941 Instagram Followers on its main Instagram account, up by 3.7% over the last month.
-
Instagram Followers
1941
-
Daily Change
0%
-
1 Month Change
3.7%
-
3 Month Change
18.1%
-
YoY Change
18.1%
Youtube Subscribers
Incyte Corporation has 276 subscribers on its main Youtube channel, up by 0.7% over the last month.
-
Youtube Subscribers
276
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
6.2%
Job Postings
Incyte Corporation currenly has an estimated 112 open job postings, up by 0.9% over the last month.
-
Job Postings
112
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
11.1%
-
YoY Change
11.1%
Reddit Mentions
Incyte Corporation has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Incyte Corporation has 6,468 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.2% over the last month.
-
Twitter Followers
6468
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.5%
-
YoY Change
0.5%
LinkedIn Followers
120,733 are following Incyte Corporation on LinkedIn, up by 1.8% over the last month.
-
LinkedIn Followers
120733
-
Daily Change
1.8%
-
1 Month Change
1.8%
-
3 Month Change
7.5%
-
YoY Change
7.5%
LinkedIn Employees
According to LinkedIn, Incyte Corporation has 3,198 employees, down by -0.1% over the last month.
-
LinkedIn Employees
3198
-
Daily Change
0.1%
-
1 Month Change
0.1%
-
3 Month Change
4.1%
-
YoY Change
4.1%
Business Outlook
According to employee reviews, the business outlook among employees at Incyte Corporation is 63 out of 100 (bullish).
-
Business Outlook
63
-
Change from Previous Month
0%
-
3 Month Change
10.5%
-
YoY Change
10.5%
News Mentions
Incyte Corporation was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0J9P.L Financials
0J9P.L Key Metrics
-
Total Revenue
$1.1B
-
Net Income
$158.2M
-
Earnings per Share
$0.82
-
Free cash flow
$262.9M
-
EBITDA
$205.2M
-
EBITDA Ratio
0.19486
-
Total Assets
$5.7B
0J9P.L 2-year Revenue & Income
0J9P.L 2-year Free Cash Flow
0J9P.L Technicals
0J9P.L SMA
0J9P.L RSI
FAQ
What's the current price of Incyte Corporation (0J9P.L) Stock?
The price of an Incyte Corporation (0J9P.L) share is $85.58.
What's the market cap of Incyte Corporation?
The current market cap of Incyte Corporation is 16.7B.
Should I buy or sell 0J9P.L?
Multiple alternative data signals suggest that Incyte Corporation stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Incyte Corporation a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Incyte Corporation stock. The bullish indicators suggest that Incyte Corporation's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Incyte Corporation (0J9P.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Incyte Corporation stock, given the bullish outlook.
What are some stocks similar to Incyte Corporation (0J9P.L) that investors often compare it to?
Incyte Corporation (0J9P.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Incyte Corporation's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Incyte Corporation's stock price to be around $93.02 in 2026. Starting from the current price of $85.58, this represents a 8.7% change in price, indicating a bullish outlook for the stock.
How to buy Incyte Corporation (0J9P.L) Stock?
Incyte Corporation stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Incyte Corporation shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.